Health care industry

CVS is considering a break up. Here’s why that could be risky

CVS is considering a break up. Here’s why that could be risky

Craig Fedirighi

A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida.  Joe Raedle | Getty Images ...

CVS is working with advisors on strategic review, sources say

CVS is working with advisors on strategic review, sources say

Craig Fedirighi

CVS Health’s board has engaged advisors to conduct a strategic review of its business, according to people familiar with the ...

Medicare Advantage shopping season arrives with a dose of confusion and some political implications

Medicare Advantage shopping season arrives with a dose of confusion and some political implications

Craig Fedirighi

Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall. That’s if their plan is ...

FDA approves Bristol Myers Squibb’s schizophrenia drug

FDA approves Bristol Myers Squibb’s schizophrenia drug

Craig Fedirighi

Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s ...

Novo Nordisk CEO testifies at Senate over weight loss drug prices

Novo Nordisk CEO testifies at Senate over weight loss drug prices

Mickey Vernon

Novo Nordisk‘s top executive faces a Senate grilling on Tuesday over the high prices of the company’s weight loss drug ...

Why Eli Lilly and Palo Alto Networks are both up on news from their competitors

Why Eli Lilly and Palo Alto Networks are both up on news from their competitors

Craig Fedirighi

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time ...

FTC sues drug middlemen for allegedly inflating insulin prices

FTC sues drug middlemen for allegedly inflating insulin prices

Mickey Vernon

Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

Craig Fedirighi

The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of ...

Pfizer’s cancer cachexia drug shows positive midstage trial results

Pfizer’s cancer cachexia drug shows positive midstage trial results

Craig Fedirighi

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...

Deep vein thrombosis while flying — who gets it and how to prevent it

Deep vein thrombosis while flying — who gets it and how to prevent it

Bob Elliott

Experts call it “economy class syndrome” — but it can happen to anyone in any class of an airplane. Deep ...